218 Recruiting Trials

Clinical Trials for Parkinson's

Parkinson's disease trials test dopamine-replacement therapies, deep brain stimulation, gene therapies, and neuroprotective compounds to slow disease progression.

Showing 15 of 218 recruiting trials

Neurologic Stem Cell Treatment Study
NA Westport, Connecticut +2 more NCT02795052
Recruiting
Investigations of Dementia in Parkinson Disease
N/A St Louis, Missouri NCT02763683
Recruiting
RESvEraTrol in Parkinson's Disease (RESET)
PHASE2 Washington D.C., District of Columbia NCT07592767
Recruiting
Recruiting
Recruiting
Recruiting
rTMS to Improve Cognition in Parkinson's
PHASE1 Chicago, Illinois +1 more NCT03836950
Recruiting
Ketamine for Veterans With Parkinson's Disease
PHASE2 San Francisco, California NCT06231563
Recruiting
Imaging Depression in Parkinson's Disease
PHASE2 New Haven, Connecticut NCT06402955
Recruiting
Tenapanor in Synucleinopathy-Related Constipation
PHASE2 Waterloo, Iowa NCT06460038
Recruiting
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →